Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)
NCT ID: NCT00822965
Last Updated: 2016-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2009-01-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. increase patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs)
2. help patients to identify if their PM or ICD has been interrogated
3. improve patient's physician-patient communication skills
4. teach patients how to identify if their device has been recalled
5. train patients what to do in case of a device recall
The educational interventions proposed, if proven to be effective by this pilot, will provide a low-cost, reproducible intervention to improve the clinical care and safe management of pacemakers (PM) and implantable cardioverter-defibrillators (ICD) in patients. The goal of the intervention will be to promote the safe use of implantable pulse generators.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations
NCT01459744
Patient and Physician Survey Determinants of Appropriate ICD Utilization
NCT01514773
A Pilot Trial of Patient Decision Aids for Implantable Cardioverter-Defibrillators (ICDs)
NCT02026102
Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement
NCT02668900
Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education
NCT00845234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Questionnaires:
The first set of questionnaires will be mailed to your home. The questionnaires will ask questions about your anxiety level and how much you know about pacemakers or implantable cardioverter-defibrillators. There will also be questions about your gender, age, ethnicity, and race. The questionnaires will take about 25 minutes to complete. When you are finished, you will mail the questionnaires to the study staff. An envelope with pre-paid postage will be provided.
Educational Packet:
After you have completed the questionnaires, you will receive an educational packet in the mail. The packet will have a DVD or a video (depending on whether you tell us you have a DVD player or a VHS player) with information on medical devices, device recall information (when and why certain devices have been recalled in the past), a list of on-line resources and benefits of routine follow-up.
Phone Interview:
The study staff will call your home 1 week after you receive the educational packet for a follow-up interview. A member of the study staff will review the packet with you. The phone call will last about 20 minutes.
Additional Questionnaires:
Approximately 2 months and at 4 months after you complete the first set of questionnaires, an additional set of questionnaires will be mailed to you. You will be asked to complete the same questionnaires as you did in the first set. At 4 months an additional questionnaire about the information in the educational packet and how useful it was to you will be included. The questionnaires will take about 25 minutes to complete. When you are finished, you will mail the questionnaires to the study staff. An envelope with pre-paid postage will be provided.
Length of Study:
You participation on this study is complete once you have completed the additional questionnaires.
This is an investigational study. Up to 104 patients will be enrolled in this study. All will be enrolled at M. D. Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Knowledge Assessments
Questionnaires + Phone Interview
Questionnaires
3 sets of questionnaires at the beginning of the study, at 2-months and at 4-months.
Phone Interviews
2 follow-up phone interviews.
Educational Packet
Video or DVD of device information, updates, recalls, on-line resources and benefits of routine follow-up for device(s).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
3 sets of questionnaires at the beginning of the study, at 2-months and at 4-months.
Phone Interviews
2 follow-up phone interviews.
Educational Packet
Video or DVD of device information, updates, recalls, on-line resources and benefits of routine follow-up for device(s).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. English-speaking (Resources to translate materials and provide interviews in Spanish language or languages other than English are not available for this study).
3. Adult patients 18 years of age or older.
Exclusion Criteria
2. Patients with self-report of hearing impairment, sight, or reading impairment that would hinder ability to complete written surveys
3. Patients who have a second implant
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike Hogg Foundation
UNKNOWN
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Suarez-Almazor, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-0163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.